| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 12/30/1997 | CA2085231C Process for the preparation of shaped, compressed controlled-release unit-dosage forms, and the compressed unit-dosage forms thus obtained |
| 12/30/1997 | CA2060833C Analgesic composition containing ibuprofen |
| 12/29/1997 | EP0814059A1 Mesoporous oxide shaped bodies |
| 12/29/1997 | EP0813879A2 Drug administration composition for iontophoresis |
| 12/29/1997 | EP0813876A1 Cyclosporin-containing soft capsule preparations |
| 12/29/1997 | EP0813865A1 Drug patch |
| 12/29/1997 | EP0813817A2 Sugar-free hard coatings and a method for obtaining them |
| 12/29/1997 | EP0813541A1 Process for producing a protein |
| 12/29/1997 | EP0813425A1 Metal radionuclide labeled proteins for diagnosis and therapy |
| 12/29/1997 | EP0813421A1 Liquid formulations for proteinic pharmaceuticals comprising at least 2 absorption enhancers |
| 12/29/1997 | EP0813413A1 Corticosteroid-containing pharmaceutical composition |
| 12/29/1997 | EP0813412A1 Gel for the local hormonotherapy of vaginal dryness |
| 12/29/1997 | EP0813407A1 Liquid aqueous pharmaceutical compositions comprising sodium alginate and potassium bicarbonate |
| 12/29/1997 | EP0813396A1 Controlled dissolution pellet containing calcium sulfate |
| 12/29/1997 | EP0813365A1 Immunoisolation |
| 12/29/1997 | EP0756863B1 Preparation process of a composition containing a heat-sensitive compound and the composition obtained thereby |
| 12/29/1997 | EP0750604B1 A method of rendering organic compounds soluble in fatty systems, novel chemical complexes of such compounds and various applications of the complexes |
| 12/29/1997 | EP0656775B1 Sustained release tablets containing bupropion |
| 12/29/1997 | EP0632727B1 Conjugates formed from heat shock proteins and oligo- or polysaccharides |
| 12/29/1997 | EP0603303B1 Antimicrobial compositions containing propylene carbonate and/or ethylene carbonate as the carrier solvent |
| 12/29/1997 | EP0552296B1 Mouse monoclonal antibodies |
| 12/28/1997 | CA2209462A1 Use in cosmetics of flexible skeleton copolymers grafted by rigid hydrophobic macromonomers; compositions prepared |
| 12/28/1997 | CA2209430A1 Cosmetic and/or dermatological acid composition containing one cross-linked poly(2-acrylamido 2-methylpropane sulfonic acid) polymer neutralized to at least 90% |
| 12/26/1997 | CA2208802A1 Sustained release-preparation |
| 12/24/1997 | WO1997048711A1 Dendrimers based on saccharides |
| 12/24/1997 | WO1997048414A1 INSULIN PREPARATIONS CONTAINING NaCl |
| 12/24/1997 | WO1997048413A1 Insulin preparations containing carbohydrates |
| 12/24/1997 | WO1997048410A1 Cyclosporin-containing soft capsule preparations |
| 12/24/1997 | WO1997048385A2 Controlled release tablet |
| 12/24/1997 | WO1997048384A2 Marking rapidly disintegrating dosage forms |
| 12/24/1997 | WO1997048371A1 Topical product formulations containing strontium for reducing skin irritation |
| 12/24/1997 | WO1997048369A2 Prophylactic and therapeutic treatment of skin sensitization and irritation |
| 12/24/1997 | WO1997042941A3 Buccal delivery system |
| 12/24/1997 | CN1168694A Polypeptide with reduced allergenicity |
| 12/24/1997 | CN1168687A Anti-oxidant compositions |
| 12/24/1997 | CN1168635A New antithrombotic formulation, process for its manufacturing, and use thereof |
| 12/24/1997 | CN1168630A Medicaments |
| 12/24/1997 | CN1168629A Adjuvant for a vaccine composition |
| 12/24/1997 | CN1036763C Pharmaceutical composition pharmaceutical granulate and process for their preparation |
| 12/24/1997 | CA2258736A1 Prophylactic and therapeutic treatment of skin sensitization and irritation |
| 12/24/1997 | CA2258726A1 Topical product formulations containing strontium for reducing skin irritation |
| 12/24/1997 | CA2258709A1 Controlled release tablet |
| 12/24/1997 | CA2258099A1 Insulin preparations containing carbohydrates |
| 12/23/1997 | US5700929 Base for coating solid enteric pharmaceutical preparations |
| 12/23/1997 | US5700848 Gel compositions prepared from crosslinkable polysaccharides, polycations and/or lipids and uses therefor |
| 12/23/1997 | US5700823 Administering 5-methylisoxazole-4-carboxylic acid-(4-trifluoromethyl)-anilide or n-(4-trifluoromethylphenyl)-2-cyano-3-hydroxycrotonamide |
| 12/23/1997 | US5700822 Treatment of platelet derived growth factor related disorders such as cancers |
| 12/23/1997 | US5700814 Active material, carrier, ph in range 8 to 10; alzheimer's disease |
| 12/23/1997 | US5700787 Capsular polysaccharide immunomodulator |
| 12/23/1997 | US5700649 Method of detection of urinary tumor associated antigen |
| 12/23/1997 | US5700514 Lozenges comprising binder and erythritol or maltitol as sweetener and process of making |
| 12/23/1997 | US5700486 Pharmaceutical compositions in the form of particles suitable for the controlled release of pharmacologically active substances and process for preparing the same compositions |
| 12/23/1997 | US5700485 Prolonged nerve blockade by the combination of local anesthetic and glucocorticoid |
| 12/23/1997 | US5700484 Sustained release microparticulate caffeine formulation |
| 12/23/1997 | US5700483 Retinoic acid-containing compositions |
| 12/23/1997 | US5700482 Subjecting to a mobile carrier phase consisting of carbon dioxide and a polar organic solvent under supercritical pressure and temperature conditions; reducing pressure; transferring to aqueous phase |
| 12/23/1997 | US5700459 Polybase and polyacid, one of which is a polymer, active material comprising antiinflammatory agent, antibiotic, enzyme inhibitor |
| 12/23/1997 | US5700410 Method of manufacturing wax matrices |
| 12/23/1997 | CA2012791C Spray gel base and spray gel preparation |
| 12/20/1997 | CA2208332A1 Drug administration composition for iontophoresis |
| 12/20/1997 | CA2207113A1 .alpha., -polyether polysiloxanes as w/o emulsifiers |
| 12/18/1997 | WO1997047644A1 T cell antigen receptor peptides |
| 12/18/1997 | WO1997047324A1 Method of using aloe vera as a biological vehicle |
| 12/18/1997 | WO1997047323A2 Chitosan drug delivery system |
| 12/18/1997 | WO1997047322A1 Medical powder |
| 12/18/1997 | WO1997047320A1 Immunstimulating lipid formulation |
| 12/18/1997 | WO1997047319A1 Uses of a chemokine receptor for inhibiting hiv-1 infection |
| 12/18/1997 | WO1997047318A1 Uses of a chemokine receptor for inhibiting hiv-1 infection |
| 12/18/1997 | WO1997047310A1 Glyceryl poly(meth)acrylate type gel based pharmaceutical compositions |
| 12/18/1997 | WO1997047292A1 Use of h2-antagonists for the manufacture of a topical composition for the treatment of colds |
| 12/18/1997 | WO1997047290A1 Liquisolid systems and methods of preparing same |
| 12/18/1997 | WO1997047289A1 Stabilized hinokitiol and compositions containing same |
| 12/18/1997 | WO1997047288A1 Microencapsulated fragrances and method for preparation |
| 12/18/1997 | WO1997047287A1 Intraorally rapidly disintegrable tablet |
| 12/18/1997 | WO1997047282A1 Cosmetic and/or pharmaceutical preparations |
| 12/18/1997 | WO1997047281A1 Use of fats to replace silicone in the production of cosmetic and/or pharmaceutical preparations |
| 12/18/1997 | WO1997047193A1 Method for the control of infestations of honeybee colonies |
| 12/18/1997 | WO1997047171A1 Skin wash composition |
| 12/18/1997 | WO1997028104A8 Buffer systems for use in stabilizing pharmaceutical preparations |
| 12/18/1997 | WO1997025052A3 Compositions comprising pvp having an average molecular weight in the range of 3,000 to 14,000 daltons |
| 12/18/1997 | DE19623383A1 Verwendung von Fettstoffen als Siliconersatz zur Herstellung von kosmetischen und/oder pharmazeutischen Zubereitungen The use of fatty compounds as a silicone substitute in the production of cosmetic and / or pharmaceutical preparations |
| 12/18/1997 | DE19622613A1 Kosmetische und/oder pharmazeutische Emulsionen Cosmetic and / or pharmaceutical emulsions |
| 12/18/1997 | CA2258264A1 Microencapsulated fragrances and method for preparation |
| 12/18/1997 | CA2258092A1 Medical powder |
| 12/18/1997 | CA2257991A1 Uses of a chemokine receptor for inhibiting hiv-1 infection |
| 12/18/1997 | CA2257990A1 Use of h2-antagonists for the manufacture of a topical composition for the treatment of colds |
| 12/18/1997 | CA2257850A1 Stabilized hinokitiol and compositions containing same |
| 12/18/1997 | CA2229981A1 Glyceryl poly(meth)acrylate type gel based pharmaceutical compositions |
| 12/18/1997 | CA2228251A1 Chitosan drug delivery system |
| 12/17/1997 | EP0812593A1 Vaccine compositions containing 3-0 deacylated monophosphoryl lipid a |
| 12/17/1997 | EP0812591A1 Injectable compositions containing Nimesulide |
| 12/17/1997 | EP0812590A2 Use of R-alpha lipoic acid for cytoprotection |
| 12/17/1997 | EP0812587A1 Transdermal compositions containing Nimesulide |
| 12/17/1997 | EP0812538A1 Preservative compositions |
| 12/17/1997 | EP0812332A1 AN IMMUNOINTERACTIVE MOLECULE WHICH BINDS THE $i(TIE)2/TEK RECEPTOR EXTRACELLULAR DOMAIN |
| 12/17/1997 | EP0812213A1 Gel form of a vaccine |
| 12/17/1997 | EP0812212A1 Compositions for the delivery of antigens |
| 12/17/1997 | EP0812209A1 Cochleate phospholipids in drug delivery |
| 12/17/1997 | EP0812208A1 Pharmaceutical compositions for controlled release of soluble receptors |
| 12/17/1997 | EP0812207A1 Morphogen-induced dentine regeneration |